Pages that link to "Q48408093"
Jump to navigation
Jump to search
The following pages link to Neostriatal mechanisms in Parkinson's disease (Q48408093):
Displaying 44 items.
- Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's Disease (Q26750370) (← links)
- Toward an integrative understanding of social phobia (Q28366405) (← links)
- The cortico-basal ganglia-thalamocortical circuit with synaptic plasticity. II. Mechanism of synergistic modulation of thalamic activity via the direct and indirect pathways through the basal ganglia (Q32065404) (← links)
- Group I metabotropic glutamate receptors: implications for brain diseases (Q33693745) (← links)
- Motor fluctuations in Parkinson's disease: a postsynaptic mechanism derived from a striatal model. (Q33768546) (← links)
- Acetylcholine-mediated modulation of striatal function (Q33838308) (← links)
- Catechol-O-methyltransferase (COMT) inhibitors in Parkinson's disease (Q33944053) (← links)
- Early Parkinson's disease: what is the best approach to treatment (Q34067384) (← links)
- Electrophysiology of dopamine in normal and denervated striatal neurons (Q34070888) (← links)
- Dopamine regulates distinctively the activity patterns of striatal output neurons in advanced parkinsonian primates (Q35138420) (← links)
- Studies of muscarinic neurotransmission with antimuscarinic toxins (Q35598396) (← links)
- Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa (Q35614156) (← links)
- Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation (Q35927547) (← links)
- Inversion of dopamine responses in striatal medium spiny neurons and involuntary movements (Q35932567) (← links)
- Treatment of Parkinson's disease : what's on the horizon? (Q36249210) (← links)
- Gene transfer of constitutively active protein kinase C into striatal neurons accelerates onset of levodopa-induced motor response alterations in parkinsonian rats (Q36969324) (← links)
- Levodopa-induced dyskinesias and their management. (Q37280804) (← links)
- Gastrodia elata Blume alleviates L-DOPA-induced dyskinesia by normalizing FosB and ERK activation in a 6-OHDA-lesioned Parkinson's disease mouse model (Q37714802) (← links)
- Loss and remodeling of striatal dendritic spines in Parkinson's disease: from homeostasis to maladaptive plasticity? (Q38766091) (← links)
- Mice with very low expression of the vesicular monoamine transporter 2 gene survive into adulthood: potential mouse model for parkinsonism (Q39460581) (← links)
- Gene expression of glutamate receptors GluR1 and NR1 is differentially modulated in striatal neurons in rats after 6-hydroxydopamine lesion (Q39656483) (← links)
- Improvement of dyskinesias with L-dopa infusion in advanced Parkinson's disease (Q40551791) (← links)
- Neural protein Olig2 acts upstream of the transcriptional regulator Sim1 to specify diencephalic dopaminergic neurons. (Q42450242) (← links)
- Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons (Q42484453) (← links)
- The α₂ adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates (Q42914087) (← links)
- Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. (Q43683702) (← links)
- Duodenal levodopa infusion in Parkinson's disease--long-term experience (Q43923057) (← links)
- Dopamine selectively reduces GABA(B) transmission onto dopaminergic neurones by an unconventional presynaptic action. (Q43943422) (← links)
- Effect of glutamatergic systems on in vivo binding of [(125)I]beta-CIT in the brain of a rat model of Parkinson's disease (Q44125241) (← links)
- Antidyskinetic effect of magnesium sulfate in MPTP-lesioned monkeys (Q44535361) (← links)
- Comparative effects of acute or chronic administration of levodopa to 6-OHDA-lesioned rats on the expression and phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in the striatum (Q44798330) (← links)
- Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment (Q45711950) (← links)
- Effects of development and dopamine depletion on striatal NMDA receptor-mediated calcium uptake (Q46164876) (← links)
- Narrow beneficial effect of dextromethorphan on levodopa-induced motor response alterations in an experimental model of parkinsonism (Q48115101) (← links)
- Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits (Q48271271) (← links)
- Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson's disease (Q48292693) (← links)
- Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and L-DOPA administration (Q48345238) (← links)
- Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's disease (Q48377970) (← links)
- Lifestyle regularity measured by the social rhythm metric in Parkinson's disease (Q48524014) (← links)
- Neurocircuitries of the basal ganglia studied in organotypic cultures: focus on tyrosine hydroxylase, nitric oxide synthase and neuropeptide immunocytochemistry (Q58365400) (← links)
- Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum (Q60623896) (← links)
- Autoradiographic analysis of N-methyl-D-aspartate receptor binding in monkey brain: effects of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine and levodopa treatment (Q64770097) (← links)
- Cortically driven Fos induction in the striatum is amplified by local dopamine D2-class receptor blockade (Q73265133) (← links)
- Evaluation of the potentiometric detection of acetylcholine and other neurotransmitters in capillary electrophoresis (Q73824944) (← links)